Onglyza Lawsuit Information
When DPP-4 inhibitor diabetes drugs like Onglyza were first introduced in the United States, they were marketed as the “new darlings of diabetes treatment –” says British Medical Journal editor Deborah Cohen, “the biggest breakthrough since the discovery of insulin nearly a hundred years before.” However, serious concerns have been raised recently about the safety of Onglyza, and the potential for the Type 2 diabetes medication to cause serious and possibly even life-threatening side effects in users.
No pharmaceutical drug is 100% safe, but studies have shown that DPP-4 inhibitors like Onglyza may pose an unreasonable risk of serious complications for users, including but not limited to pancreatitis, heart failure and pancreatic cancer. Unfortunately, when drug manufacturing companies conceal these drug risks from the public, consumers are robbed of their right to make educated decisions about which medications are safe for them to use, and which aren’t. If you took Onglyza in the past, and you have since been diagnosed with one or more serious medical conditions, you may be entitled to reimbursement for your losses. Consult an experienced Onglyza attorney today to explore your possible compensation options.